Hubei Jumpcan Pharmaceutical Statistics
Total Valuation
Hubei Jumpcan Pharmaceutical has a market cap or net worth of CNY 25.38 billion. The enterprise value is 15.12 billion.
Market Cap | 25.38B |
Enterprise Value | 15.12B |
Important Dates
The next estimated earnings date is Wednesday, October 23, 2024.
Earnings Date | Oct 23, 2024 |
Ex-Dividend Date | Jun 17, 2024 |
Share Statistics
Hubei Jumpcan Pharmaceutical has 921.70 million shares outstanding. The number of shares has increased by 0.24% in one year.
Shares Outstanding | 921.70M |
Shares Change (YoY) | +0.24% |
Shares Change (QoQ) | +0.91% |
Owned by Insiders (%) | 5.25% |
Owned by Institutions (%) | 12.54% |
Float | 340.37M |
Valuation Ratios
The trailing PE ratio is 8.97 and the forward PE ratio is 8.33.
PE Ratio | 8.97 |
Forward PE | 8.33 |
PS Ratio | 2.79 |
PB Ratio | 1.88 |
P/FCF Ratio | 9.95 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.98, with an EV/FCF ratio of 5.92.
EV / Earnings | 5.36 |
EV / Sales | 1.67 |
EV / EBITDA | 4.98 |
EV / EBIT | 5.52 |
EV / FCF | 5.92 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 10.00.
Current Ratio | 3.29 |
Quick Ratio | 3.12 |
Debt / Equity | 10.00 |
Debt / EBITDA | 0.45 |
Debt / FCF | 0.53 |
Interest Coverage | 101.83 |
Financial Efficiency
Return on equity (ROE) is 22.23% and return on invested capital (ROIC) is 12.52%.
Return on Equity (ROE) | 22.23% |
Return on Assets (ROA) | 9.94% |
Return on Capital (ROIC) | 12.52% |
Revenue Per Employee | 1.73M |
Profits Per Employee | 539,435 |
Employee Count | 5,230 |
Asset Turnover | 0.53 |
Inventory Turnover | 2.86 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.08% in the last 52 weeks. The beta is 0.14, so Hubei Jumpcan Pharmaceutical's price volatility has been lower than the market average.
Beta (5Y) | 0.14 |
52-Week Price Change | +7.08% |
50-Day Moving Average | 31.66 |
200-Day Moving Average | 34.42 |
Relative Strength Index (RSI) | 31.05 |
Average Volume (20 Days) | 8,947,661 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hubei Jumpcan Pharmaceutical had revenue of CNY 9.06 billion and earned 2.82 billion in profits. Earnings per share was 3.07.
Revenue | 9.06B |
Gross Profit | 7.30B |
Operating Income | 2.74B |
Pretax Income | 3.30B |
Net Income | 2.82B |
EBITDA | 3.03B |
EBIT | 2.74B |
Earnings Per Share (EPS) | 3.07 |
Balance Sheet
The company has 11.64 billion in cash and 1.35 billion in debt, giving a net cash position of 10.29 billion or 11.16 per share.
Cash & Cash Equivalents | 11.64B |
Total Debt | 1.35B |
Net Cash | 10.29B |
Net Cash Per Share | 11.16 |
Equity (Book Value) | 13.53B |
Book Value Per Share | 14.65 |
Working Capital | 9.90B |
Cash Flow
In the last 12 months, operating cash flow was 2.83 billion and capital expenditures -280.63 million, giving a free cash flow of 2.55 billion.
Operating Cash Flow | 2.83B |
Capital Expenditures | -280.63M |
Free Cash Flow | 2.55B |
FCF Per Share | 2.77 |
Margins
Gross margin is 80.60%, with operating and profit margins of 30.24% and 31.14%.
Gross Margin | 80.60% |
Operating Margin | 30.24% |
Pretax Margin | 36.45% |
Profit Margin | 31.14% |
EBITDA Margin | 33.48% |
EBIT Margin | 30.24% |
FCF Margin | 28.17% |
Dividends & Yields
This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 4.72%.
Dividend Per Share | 1.30 |
Dividend Yield | 4.72% |
Dividend Growth (YoY) | 47.73% |
Years of Dividend Growth | 2 |
Payout Ratio | 60.44% |
Buyback Yield | -0.24% |
Shareholder Yield | 4.49% |
Earnings Yield | 11.15% |
FCF Yield | 10.05% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |